|
[Related PubMed/MEDLINE] Total Number of Papers: 108
|
|
|
[Display Entries]
|
>> all entries
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension. |
Cav-1 |
2 |
2022 |
Genetic and immune changes in Tibetan high-altitude populations contribute to biological adaptation to hypoxia. |
EGLN1, EPAS1, ERBB3, GROa, Hct, HGB, HIF-1alpha, HIF-2alpha, IL-8, MCH, MCHC, MCV, MIP-1b, SNPs, TNFRII |
3 |
2022 |
GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells. |
GPER, HIF-1alpha, UCH-L1 |
4 |
2022 |
HOCI Probe CPP Induces the Differentiation of Human Dermal Fibroblasts into Vascular Endothelial Cells through PHD2/HIF-1alpha/HEY1 Signaling Pathway. |
HDFs, HOCl |
5 |
2022 |
Hypoxia-induced HIF1alpha activation regulates small extracellular vesicle release in human embryonic kidney cells. |
EVs, HIFs |
6 |
2022 |
In Situ Inhibitor Synthesis and Screening by Fluorescence Polarization: An Efficient Approach for Accelerating Drug Discovery. |
ISISS |
7 |
2022 |
Iron increases lipid deposition via oxidative stress-mediated mitochondrial dysfunction and the HIF1alpha-PPARgamma pathway. |
HIF1alpha |
8 |
2022 |
Metformin and simvastatin synergistically suppress endothelin 1-induced hypoxia and angiogenesis in multiple cancer types. |
ET-1, MET, SVA |
9 |
2022 |
PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis. |
ASMCs, BM, ECs, HIF, RV |
10 |
2022 |
Production of functional recombinant prolyl hydroxylase-2 enzyme in insect cells for small molecule inhibitor screening studies. |
HIF, VBC |
11 |
2022 |
Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report. |
ESAs |
12 |
2022 |
Screening of prolyl hydroxylase 2 inhibitors based on quantitative strategy of peptides. |
MEKC, TCMs |
13 |
2022 |
Strategic Modification of Gut Microbiota through Oral Bacteriotherapy Influences Hypoxia Inducible Factor-1alpha: Therapeutic Implication in Alzheimer's Disease. |
AD, HIF-1alpha, iNOS |
14 |
2022 |
Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia. |
EPO, HIF-alpha |
15 |
2022 |
The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia. |
HIF |
16 |
2021 |
alpha-Ketoglutarate Inhibits Thrombosis and Inflammation by Prolyl Hydroxylase-2 Mediated Inactivation of Phospho-Akt. |
alpha-KG, DBT, pAkt1 |
17 |
2021 |
BNIP3 in melanoma: isn't it IRONic? |
Bcl-2, HIF-1alpha, Ncoa4 |
18 |
2021 |
Costunolide ameliorates colitis via specific inhibition of HIF1alpha/glycolysis-mediated Th17 differentiation. |
DAI, DSS, MPO, UC |
19 |
2021 |
In silico identification of prolyl hydroxylase inhibitor by per-residue energy decomposition-based pharmacophore approach. |
HIF, MD, MM-GBSA, PRED |
20 |
2021 |
Influence of hypoxia on biochemical aspects and on expression of genes related to oxygen-homeostasis of the Amazonian cichlid Astronotus ocellatus (Agassiz, 1831). |
HIF-1alpha |
21 |
2021 |
kappa-opioid receptor stimulation alleviates rat vascular smooth muscle cell calcification via PFKFB3-lactate signaling. |
ALP, beta-GP, LDH, VSMCs |
22 |
2021 |
LRP5 Regulates HIF-1alpha Stability via Interaction with PHD2 in Ischemic Myocardium. |
HIF-1alpha, LRP5 |
23 |
2021 |
Overexpression of MicroRNA-429 Transgene Into the Renal Medulla Attenuated Salt-Sensitive Hypertension in Dahl S Rats. |
HIF |
24 |
2021 |
PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1alpha/VEGF pathway. |
BRB, DME, DMOG, HIF-1, HRMECs, RT-qPCR, TEER, VEGF, ZO-1 |
25 |
2021 |
Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway. |
ITGA5, ITGB1, RGS5, VEGF |
26 |
2021 |
Selinexor decreases HIF-1alpha via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity. |
CRM1, HIFs, NPCs |
27 |
2021 |
The DpdtbA induced EMT inhibition in gastric cancer cell lines was through ferritinophagy-mediated activation of p53 and PHD2/hif-1alpha pathway. |
DpdtbA, EMT, ROS |
28 |
2020 |
Cystathione beta-synthase regulates HIF-1alpha stability through persulfidation of PHD2. |
CBS, HIF-1alpha |
29 |
2020 |
Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury. |
Ang II, AT1R, ECs, HIF, PHD2ECKO, ROS, WT |
30 |
2020 |
Inhibition of oxygen-sensing prolyl hydroxylases increases lipid accumulation in human primary tubular epithelial cells without inducing ER stress. |
AMPK, CsA, ER, HIF, hPTEC, PHD, PHDi |
31 |
2020 |
Macrophage HIF-1alpha mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M. |
AT, HFD, HIF-1alpha, Irak-M, PHDs |
32 |
2020 |
Mitochondrial Dysfunction Inhibits Hypoxia-Induced HIF-1alpha Stabilization and Expression of Its Downstream Targets. |
CAIX, HIF-1alpha, HIF-2alpha, mtDNA, OXPHOS, ROS, VEGF |
33 |
2020 |
Possible mechanisms by which silkworm faeces extract ameliorates adenine-induced renal anaemia in rats. |
ELISA, EPO, HIF-2alpha, IL-6, rhEPO, SFE |
34 |
2020 |
Prolyl hydroxylase 2 silencing enhances the paracrine effects of mesenchymal stem cells on necrotizing enterocolitis in an NF-kappaB-dependent mechanism. |
BM-MSCs, MSC-CM, NEC, PHDMSC-CM |
35 |
2020 |
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2. |
--- |
36 |
2019 |
A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas. |
MAX, NF1, RET, TMEM127, VHL |
37 |
2019 |
Discovery of prolyl hydroxylase 2 inhibitors with new chemical scaffolds as in vivo active erythropoietin inducers through a combined virtual screening strategy. |
EPO, HIF |
38 |
2019 |
Downregulation of Proline Hydroxylase 2 and Upregulation of Hypoxia-Inducible Factor 1alpha are Associated with Endometrial Cancer Aggressiveness. |
HIF-1alpha, LVSI |
39 |
2019 |
Early-Life Iron Deficiency Alters Glucose Transporter-1 Expression in the Adult Rodent Hippocampus. |
FID, GLUT, HIF, ID, WT |
40 |
2019 |
Genetic variants at the EGLN1 locus associated with high-altitude adaptation in Tibetans are absent or found at low frequency in highland Andeans. |
HIF |
41 |
2019 |
Intrabody against prolyl hydroxylase 2 ameliorates acetaminophen-induced acute liver injury in mice via concomitant promotion of angiogenesis and redox homeostasis. |
AILI, HIF-1 |
42 |
2019 |
Intrabody against prolyl hydroxylase 2 promotes angiogenesis by stabilizing hypoxia-inducible factor-1alpha. |
CAMs, ER, HIF, HUVECs, scFv |
43 |
2019 |
PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-kappaB activity. |
EMT, MDSCs, TAMs |
44 |
2019 |
Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light. |
--- |
45 |
2019 |
Quantum Blue Reduces the Severity of Woody Breast Myopathy via Modulation of Oxygen Homeostasis-Related Genes in Broiler Chickens. |
DRS, Hb, HBM, Heph, NC, QB, WB |
46 |
2019 |
Targeting ERbeta in Macrophage Reduces Crown-like Structures in Adipose Tissue by Inhibiting Osteopontin and HIF-1alpha. |
CLS, CNS, ERbeta, HIF-1alpha, OPN, SAT, VAT |
47 |
2019 |
The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment. |
HIF-1alpha, PHDs |
48 |
2018 |
Hepatic PHD2/HIF-1alpha axis is involved in postexercise systemic energy homeostasis. |
HIF-1alpha, LKO |
49 |
2018 |
Hypoxia Upregulates Estrogen Receptor beta in Pulmonary Artery Endothelial Cells in a HIF-1alpha-Dependent Manner. |
ER, HIF-1alpha, HPH, PAECs |
50 |
2018 |
PAI-1 is a novel component of the miR-17~92 signaling that regulates pulmonary artery smooth muscle cell phenotypes. |
PAI-1, PASMCs, PDLIM5, PH, UTR |
51 |
2018 |
Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cells. |
HIF-1alpha, PPP, SREBP-1c |
52 |
2018 |
Regulatory Role of Endothelial PHD2 in the Hepatic Steatosis. |
Ang-2, ANP, HFD, NAFLD |
53 |
2018 |
Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the alpha-Ketoglutarate Signaling Pathway. |
alpha-KG, FH, TKT, TNBC |
54 |
2018 |
Understanding molecular mechanisms of Rhodiola rosea for the treatment of acute mountain sickness through computational approaches (a STROBE-compliant article). |
AMS, ARD1, HDM2, HIF-1, OS-9, RACK1, SSAT1, TCM |
55 |
2018 |
ZNF750 inhibited the malignant progression of oral squamous cell carcinoma by regulating tumor vascular microenvironment. |
ITGA5, ITGB1, VEGF, ZNF750 |
56 |
2017 |
Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling. |
alpha-KG, Shh |
57 |
2017 |
Hypoxia inducible factor-1alpha mediates the profibrotic effect of albumin in renal tubular cells. |
CKD, EMT, HIF, TIMP |
58 |
2017 |
Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction. |
HIF-1alpha, UTMD |
59 |
2016 |
15-Deoxy-Delta12,14-prostaglandin J2 stabilizes hypoxia inducible factor-1alpha through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2. |
HIF-1, HO-1, ROS |
60 |
2016 |
Computational analysis of prolyl hydroxylase domain-containing protein 2 (PHD2) mutations promoting polycythemia insurgence in humans. |
--- |
61 |
2016 |
Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer. |
EGFR, HIF-1alpha |
62 |
2016 |
Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells. |
EPO, HIF |
63 |
2016 |
Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling. |
FSP-1, PAH |
64 |
2016 |
LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2alpha/Notch3 pathways. |
SIRT3 |
65 |
2016 |
miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation. |
HIF, HIF1, PASMC, PHDs, SMC |
66 |
2016 |
Neuronal prolyl-4-hydroxylase 2 deficiency improves cognitive abilities in a murine model of cerebral hypoperfusion. |
EPO, HIF, VEGF |
67 |
2016 |
Prolyl hydroxylase 2 (PHD2) inhibition protects human renal epithelial cells and mice kidney from hypoxia injury. |
HIF-alpha |
68 |
2016 |
Prolyl hydroxylase mediated inhibition of fatty acid synthase to combat tumor growth in mammary gland carcinoma. |
HIF |
69 |
2016 |
Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2alpha. |
PAH |
70 |
2015 |
A Systems Pharmacology Model of Erythropoiesis in Mice Induced by Small Molecule Inhibitor of Prolyl Hydroxylase Enzymes. |
EPO |
71 |
2015 |
Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP. |
BBB, HIF-1alpha, JPD, MMP-9, MRI, MWM, SHR/SP, UCAO, VCI, WM |
72 |
2015 |
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle. |
MEFs, Phd2-LKO |
73 |
2015 |
Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress. |
EPO, FLTIM, HIF-1alpha, I/R, MB, OGD |
74 |
2015 |
Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4alpha Expression. |
EPO, HCC, HIF, HNF-4alpha |
75 |
2015 |
Suppression of vascular network formation by chronic hypoxia and prolyl-hydroxylase 2 (phd2) deficiency during vertebrate development. |
HIF, PHD |
76 |
2015 |
The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts. |
CAFs |
77 |
2015 |
The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1alpha Stability and Angiogenesis. |
CAMs, FAK, HIF, HMT, HUVECs, MMP-2, VEGF, VEGFR2 |
78 |
2015 |
[Effects of Bushen Wenyang Huayu Recipe on Expressions of HIF-1alpha, PHD2, and VHL in Endometriosis Rats with Shen Yang Deficiency Blood Stasis Syndrome]. |
BWHR, cAMP, cGMP, CM, EM, HIF-1alpha, VHL, WM |
79 |
2014 |
A genetic mechanism for Tibetan high-altitude adaptation. |
HIFs |
80 |
2014 |
Lactoferrin from bovine colostrum regulates prolyl hydroxylase 2 activity and prevents prion protein-mediated neuronal cell damage via cellular prion protein. |
HIF-1alpha, PrP |
81 |
2014 |
NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro. |
CMECs, I/R, NOX4, ROS |
82 |
2014 |
Prolyl-4-hydroxylase 2 enhances hypoxia-induced glioblastoma cell death by regulating the gene expression of hypoxia-inducible factor-alpha. |
HIF |
83 |
2013 |
Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1. |
ET-1, HIF-1, PASMCs |
84 |
2013 |
Cell type-specific dependency on the PI3K/Akt signaling pathway for the endogenous Epo and VEGF induction by baicalein in neurons versus astrocytes. |
EPO, PI3K, VEGF |
85 |
2013 |
Estrogen receptor beta sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription. |
EGLN1, ERbeta, HIF-1alpha |
86 |
2013 |
HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress. |
BM, HIF, HSC, PHDs |
87 |
2013 |
Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice. |
HIF |
88 |
2013 |
Periostin inhibits hypoxia-induced apoptosis in human periodontal ligament cells via TGF-beta signaling. |
PDL, POSTN, rhPOSTN |
89 |
2013 |
Silencing of HIF prolyl-hydroxylase 2 gene in the renal medulla attenuates salt-sensitive hypertension in Dahl S rats. |
COX-2, HIF, HO-1, shRNA |
90 |
2013 |
Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change. |
2OG, CODD, HDX, HIF, NODD |
91 |
2012 |
Anti-inflammatory properties of histone deacetylase inhibitors: a mechanistic study. |
HIF-1alpha, iNOS, NO, SAHA, TNF-alpha |
92 |
2012 |
Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle. |
COPD, CS, HIF-1alpha, UBE2D1, VEGF, VHL |
93 |
2012 |
Hypoxia inducible factor-1alpha-mediated gene activation in the regulation of renal medullary function and salt sensitivity of blood pressure. |
COX-2, HIF, HO-1, NOS |
94 |
2012 |
Inhibition of transforming growth factor beta1/Smad3 signaling decreases hypoxia-inducible factor-1alpha protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells. |
HIF-1alpha, SIS3, TGF-beta1 |
95 |
2012 |
Investigation of possible endogenous hypoxia markers in colorectal cancer. |
CAIX, DFS, GLUT1, MCT1, MVD, OS |
96 |
2012 |
Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia. |
HIF-1, ROS |
97 |
2012 |
Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH). |
alpha-KG, EPR, FIH, HIF |
98 |
2011 |
LDH-A influences hypoxia-inducible factor 1alpha (HIF1 alpha) and is critical for growth of HT29 colon carcinoma cells in vivo. |
CAIX, FIH, HIF1alpha, Hif1alpha, LDH, VEGF |
99 |
2011 |
Molecular imaging of RNA interference therapy targeting PHD2 for treatment of myocardial ischemia. |
Fluc, HIF-1alpha, HRE, shRNA |
100 |
2011 |
Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer. |
HIF, PHD, siRNAs |
|